» Articles » PMID: 30215874

Dynamical Ventral Tegmental Area Circuit Mechanisms of Alcohol-dependent Dopamine Release

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2018 Sep 15
PMID 30215874
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A large body of data has identified numerous molecular targets through which ethanol (EtOH) acts on brain circuits. Yet how these multiple mechanisms interact to result in dysregulated dopamine (DA) release under the influence of alcohol in vivo remains unclear. In this manuscript, we delineate potential circuit-level mechanisms responsible for EtOH-dependent dysregulation of DA release from the ventral tegmental area (VTA) into its projection areas. For this purpose, we constructed a circuit model of the VTA that integrates realistic Glutamatergic (Glu) inputs and reproduces DA release observed experimentally. We modelled the concentration-dependent effects of EtOH on its principal VTA targets. We calibrated the model to reproduce the inverted U-shape dose dependence of DA neuron activity on EtOH concentration. The model suggests a primary role of EtOH-induced boost in the I and AMPA currents in the DA firing-rate/bursting increase. This is counteracted by potentiated GABA transmission that decreases DA neuron activity at higher EtOH concentrations. Thus, the model connects well-established in vitro pharmacological EtOH targets with its in vivo influence on neuronal activity. Furthermore, we predict that increases in VTA activity produced by moderate EtOH doses require partial synchrony and relatively low rates of the Glu afferents. We propose that the increased frequency of transient (phasic) DA peaks evoked by EtOH results from synchronous population bursts in VTA DA neurons. Our model predicts that the impact of acute ETOH on dopamine release is critically shaped by the structure of the cortical inputs to the VTA.

Citing Articles

The potential therapeutic roles of Rho GTPases in substance dependence.

Ru Q, Wang Y, Zhou E, Chen L, Wu Y Front Mol Neurosci. 2023; 16:1125277.

PMID: 37063367 PMC: 10097952. DOI: 10.3389/fnmol.2023.1125277.


Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index.

Blum K, Han D, Bowirrat A, Downs B, Bagchi D, Thanos P J Pers Med. 2022; 12(11).

PMID: 36579510 PMC: 9696872. DOI: 10.3390/jpm12111772.


Effects of baclofen on insular gain anticipation in alcohol-dependent patients - a randomized, placebo-controlled, pharmaco-fMRI pilot trial.

Pelz P, Genauck A, Lorenz R, Wustenberg T, Wackerhagen C, Charlet K Psychopharmacology (Berl). 2022; 240(1):171-183.

PMID: 36538099 PMC: 9816215. DOI: 10.1007/s00213-022-06291-6.


Understanding Emotions: Origins and Roles of the Amygdala.

Simic G, Tkalcic M, Vukic V, Mulc D, Spanic E, Sagud M Biomolecules. 2021; 11(6).

PMID: 34072960 PMC: 8228195. DOI: 10.3390/biom11060823.


The Role of Glia in Addiction: Dopamine as a Modulator of Glial Responses in Addiction.

Jimenez-Gonzalez A, Gomez-Acevedo C, Ochoa-Aguilar A, Chavarria A Cell Mol Neurobiol. 2021; 42(7):2109-2120.

PMID: 34057683 PMC: 11421599. DOI: 10.1007/s10571-021-01105-3.